This tiny float of 2.3 million shares and market cap of $2.05 million seems to be bottoming out. With news it will explode and fill multiple gaps to the upside. They currently have a drug in clinical trials. Positive results will send this "to the moon."
In the meantime, without news, it is likely to hit $1.40's in the coming days/ weeks. The 52-week high is $81.90!!!
Although, the RSI is oversold, I still don't see the bottom here. MACD just turned red, and the trend indicates that it could go as low as $0.05's. I would wait before buying any shares of this. Or play for a dead cat bounce.
I see this topping out around $9.70 before dropping back down to fill a tiny gap around $2.31. Remember, we're still in a bear market. No MOASS happening here. Trade accordingly.
The chart shows that it is headed down to the $0.50's before earnings pump will occur. My analysis is that it can go down to $0.50's and pump to $1.20-$1.30's before earnings in two weeks. That's over a 100% run but be patient before buying, as it could drop a lot more from this point.
A bullish engulfing candlestick is present at a line of support. There's also a massive gap to fill. First price target is $0.1277.
Volume is also increasing, and RSI is in the oversold area. Low risk, high reward potential swing play.
